Salix sues rival over generic medicine
Published: Tue, Sep. 09, 2008 01:22PM
Modified Tue, Sep. 09, 2008 01:28PM
E-Mail
Print
tool name
closeMorrisville -- Salix Pharmaceuticals, a Morrisville company specializing in gastrointestinal medicines, has filed a lawsuit to prevent a competitor from bringing to market a cheaper, generic version of its bowel cleanser Osmoprep.
New Jersey-based Novel Laboratories has asked the Food and Drug Administration for approval to sell generic Osmoprep. But Salix sued Novel in federal court, claiming its license to protect Osmoprep's patent is valid until May 18, 2013.
Filed Monday in New Jersey, it is the second patent infringement lawsuit Salix has filed against Novel this year. The other one involves Moviprep, another Salix bowel cleanser under pressure from generic competition.
More Business
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.
